Skip to main content

Advertisement

Log in

Does delivering more dialysis improve clinical outcomes? What randomized controlled trials have shown

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Some randomized controlled trials (RCTs) have sought to determine whether different dialysis techniques, dialysis doses and frequencies of treatment are able to improve clinical outcomes in end-stage kidney disease (ESKD). Virtually all of these RCTs were enacted on the premise that ‘more’ haemodialysis might improve clinical outcomes compared to ‘conventional’ haemodialysis. Aim of the present narrative review was to analyse these landmark RCTs by posing the following question: were their intervention strategies (i.e., earlier dialysis start, higher haemodialysis dose, intensive haemodialysis, increase in convective transport, starting haemodialysis with three sessions per week) able to improve clinical outcomes? The answer is no. There are at least two main reasons why many RCTs have failed to demonstrate the expected benefits thus far: (1) in general, RCTs included relatively small cohorts and short follow-ups, thus producing low event rates and limited statistical power; (2) the designs of these studies did not take into account that ESKD does not result from a single disease entity: it is a collection of different diseases and subtypes of kidney dysfunction. Patients with advanced kidney failure requiring dialysis treatment differ on a multitude of levels including residual kidney function, biochemical parameters (e.g., acid base balance, serum electrolytes, mineral and bone disorder), and volume overload. In conclusion, the different intervention strategies of the RCTs herein reviewed were not able to improve clinical outcomes of ESKD patients. Higher quality studies are needed to guide patients and clinicians in the decision-making process. Future RCTs should account for the heterogeneity of patients when considering inclusion/exclusion criteria and study design, and should a priori consider subgroup analyses to highlight specific subgroups that can benefit most from a particular intervention.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Chan CT, Covic A, Craig JC, Davenport A, Kasiske BL, Kuhlmann MK, Levin NW, Li PK, Locatelli F, Rocco MV, Wheeler DC (2013) Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int 83:359–371. https://doi.org/10.1038/ki.2012.450

    Article  PubMed  Google Scholar 

  2. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA, IDEAL Study (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619. https://doi.org/10.1056/NEJMoa1000552

    Article  CAS  PubMed  Google Scholar 

  3. Lowrie EG, Laird NM, Parker TF, Sargent JA (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181. https://doi.org/10.1056/NEJM198111123052003

    Article  CAS  PubMed  Google Scholar 

  4. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019. https://doi.org/10.1056/NEJMoa021583

    Article  PubMed  Google Scholar 

  5. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R, Membrane Permeability Outcome (MPO) Study Group (2009) Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20:645–654. https://doi.org/10.1681/ASN.2008060590

    Article  PubMed  PubMed Central  Google Scholar 

  6. Asci G, Tz H, Ozkahya M, Duman S, Demirci MS, Cirit M, Sipahi S, Dheir H, Bozkurt D, Kircelli F, Ok ES, Erten S, Ertilav M, Kose T, Basci A, Raimann JG, Levin NW, Ok E, EGE Study Group (2013) The impact of membrane permeability and dialysate purity on cardiovascular outcomes. J Am Soc Nephrol 24:1014–1023. https://doi.org/10.1681/ASN.2012090908

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, Basile C, David S, Feriani M, Montagna G, Di Iorio BR, Memoli B, Cravero R, Battaglia G, Zoccali C (2010) Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 21:1798–1807. https://doi.org/10.1681/ASN.2010030280

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, ter Wee PM, Blankestijn PJ, CONTRAST Investigators (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23:1087–1096. https://doi.org/10.1681/ASN.2011121140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, Hur E, Demirci MS, Demirci C, Duman S, Basci A, Adam SM, Isik IO, Zengin M, Suleymanlar G, Yilmaz ME, Ozkahya M, Turkish Online Haemodiafiltration Study (2013) Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 28:192–202. https://doi.org/10.1093/ndt/gfs407

    Article  PubMed  Google Scholar 

  10. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A, ESHOL Study Group (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24:487–497. https://doi.org/10.1681/ASN.2012080875

    Article  PubMed  PubMed Central  Google Scholar 

  11. Morena M, Jaussent A, Chalabi L, Leray-Moragues H, Chenine L, Debure A, Thibaudin D, Azzouz L, Patrier L, Maurice F, Nicoud P, Durand C, Seigneuric B, Dupuy AM, Picot MC, Cristol JP, Canaud B, FRENCHIE Study Investigators (2017) Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int 91:1495–1509. https://doi.org/10.1016/j.kint.2017.01.013

    Article  PubMed  Google Scholar 

  12. Wizemann V, Lotz C, Techert F, Uthoff S (2000) On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15(Suppl 1):43–48. https://doi.org/10.1093/oxfordjournals.ndt.a027963

    Article  PubMed  Google Scholar 

  13. Schiffl H (2007) Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 12:26–33 (PMID: 17363355)

    CAS  PubMed  Google Scholar 

  14. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363:2287–2300. https://doi.org/10.1056/NEJMoa1001593

    Article  CAS  Google Scholar 

  15. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T et al (2011) Frequent Hemodialysis Network (FHN) Trial Group. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80:1080–1091. https://doi.org/10.1038/ki.2011.213

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wang C, Lv LS, Huang H, Guan J, Ye Z, Li S, Wang Y, Lou T, Liu X (2017) Initiation time of renal replacement therapy on patients with acute kidney injury: a systematic review and meta-analysis of 8179 participants. Nephrology (Carlton) 22:7–18. https://doi.org/10.1111/nep.12890

    Article  Google Scholar 

  17. STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group, Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D et al (2020) Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383:240–251. https://doi.org/10.1056/NEJMoa2000741

    Article  Google Scholar 

  18. Hakim RM, Lazarus JM (1995) Initiation of dialysis. J Am Soc Nephrol 6:1319–1328. https://doi.org/10.1681/ASN.V651319

    Article  CAS  PubMed  Google Scholar 

  19. Bonomini V, Feletti C, Stefoni S, Vangelista A (1986) Early dialysis and renal transplantation. Nephron 44:267–271. https://doi.org/10.1159/000184004

    Article  CAS  PubMed  Google Scholar 

  20. Tattersall J, Greenwood R, Farrington K (1995) Urea kinetics and when to commence dialysis. Am J Nephrol 15:283–289. https://doi.org/10.1159/000168850

    Article  CAS  PubMed  Google Scholar 

  21. O’Hare AM, Choi AI, Boscardin WJ, Clinton WL, Zawadzki I, Hebert PL, Kurella Tamura M, Taylor L, Larson EB (2011) Trends in timing of initiation of chronic dialysis in the United States. Arch Intern Med 10(171):1663–1669. https://doi.org/10.1001/archinternmed.2011.436

    Article  Google Scholar 

  22. National Kidney Foundation (2015) KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66:884–930. https://doi.org/10.1053/j.ajkd.2015.07.015

    Article  Google Scholar 

  23. Rivara MB, Mehrotra R (2017) Timing of dialysis initiation: what has changed since IDEAL? Semin Nephrol 37:181–193. https://doi.org/10.1016/j.semnephrol.2016.12.008

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fu EL, Evans M, Carrero J-J, Putter H, Clase CM, Caskey FJ, Szymczak M, Torino C, Chesnaye NC, Jager KJ, Wanner C, Dekker FW, van Diepen M (2021) Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ 375:e066306. https://doi.org/10.1136/bmj-2021-066306

    Article  PubMed  PubMed Central  Google Scholar 

  25. Port FK, Orzol SM, Held PJ, Wolfe RA (1998) Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis 32(6 Suppl 4):S34–S38. https://doi.org/10.1016/s0272-6386(98)70159-3

    Article  CAS  PubMed  Google Scholar 

  26. Kraus MA, Kansal S, Copland M, Komenda P, Weinhandl ED, Bakris GL, Chan CT, Fluck RJ, Burkart JM (2016) Intensive hemodialysis and potential risks with increasing treatment. Am J Kidney Dis 68(5S1):S51–S58. https://doi.org/10.1053/j.ajkd.2016.05.020

    Article  PubMed  Google Scholar 

  27. Fluck RJ, Fouque D, Lockridge RS Jr (2014) Nephrologists’ perspectives on dialysis treatment: results of an international survey. BMC Nephrol 15:16. https://doi.org/10.1186/1471-2369-15-16

    Article  PubMed  PubMed Central  Google Scholar 

  28. Foley RN, Gilbertson DT, Murray T, Collins AJ (2011) Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365:1099–1107. https://doi.org/10.1056/NEJMoa1103313

    Article  CAS  PubMed  Google Scholar 

  29. Chertow GM, Levin NW, Beck GJ, Daugirdas JT, Eggers PW, Kliger AS, Larive B, Rocco MV, Greene T, Frequent Hemodialysis Network (FHN) Trials Group (2016) Long-term effects of frequent in-center hemodialysis. J Am Soc Nephrol 27:1830–1836. https://doi.org/10.1681/ASN.2015040426

    Article  CAS  PubMed  Google Scholar 

  30. Rocco MV, Daugirdas JT, Greene T, Lockridge RS, Chan C, Pierratos A, Lindsay R, Larive B, Chertow GM, Beck GJ, Eggers PW, Kliger AS, FHN Trial Group (2015) Long-term effects of frequent nocturnal hemodialysis on mortality: the frequent hemodialysis network (FHN) nocturnal trial. Am J Kidney Dis 66:459–468. https://doi.org/10.1053/j.ajkd.2015.02.331

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jardine MJ, Zuo L, Gray NA, de Zoysa JR, Chan CT, Gallagher MP, Monaghan H, Grieve SM, Puranik R, Lin H, Eris JM, Zhang L, Xu J, Howard K, Lo S, Cass A, Perkovic V, ACTIVE Dialysis Steering Committee; Paul (2017) A trial of extending hemodialysis hours and quality of life. J Am Soc Nephrol 28:1898–1911. https://doi.org/10.1681/ASN.2015111225

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, Winkelmayer WC, Ellenberg SS, Cifelli D, Madigan R, Young A, Angeletti M, Wingard RL, Kahn C, Nissenson AR, Maddux FW, Abbott KC, Landis JR (2019) The TiME trial: a fully embedded, cluster-randomized, pragmatic trial of hemodialysis session duration. J Am Soc Nephrol 30:890–903. https://doi.org/10.1681/ASN.2018090945

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tattersall JE, Ward RA, EUDIAL Group (2013) Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 28:542–550. https://doi.org/10.1093/ndt/gfs530

    Article  CAS  PubMed  Google Scholar 

  34. Mercadal L, Franck JE, Metzger M, Urena Torres P, de Cornelissen F, Edet S, Béchade C, Vigneau C, Drüeke T, Jacquelinet C, Stengel B, Registry REIN (2016) Hemodiafiltration versus hemodialysis and survival in patients with ESRD: The French Renal Epidemiology and Information Network (REIN) Registry. Am J Kidney Dis 68:247–255. https://doi.org/10.1053/j.ajkd.2015.11.016

    Article  PubMed  Google Scholar 

  35. Blankestijn PJ, Fischer KI, Barth C, Cromm K, Canaud B, Davenport A, Grobbee DE, Hegbrant J, Roes KC, Rose M, Strippoli GF, Vernooij RW, Woodward M, de Wit GA, Bots ML (2020) Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol. BMJ Open 10:e033228. https://doi.org/10.1136/bmjopen-2019-033228

    Article  PubMed  PubMed Central  Google Scholar 

  36. Vilar E, Kaja Kamal RM, Fotheringham J, Busby A, Berdeprado J, Kislowska E, Wellsted D, Alchi B, Burton JO, Davenport A, Farrington K (2021) A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function. Kidney Int. https://doi.org/10.1016/j.kint.2021.07.025

    Article  PubMed  Google Scholar 

  37. Grimes DA, Schulz KF (2002) An overview of clinical research: the lay of the land. Lancet 359:57–61. https://doi.org/10.1016/S0140-6736(02)07283-5

    Article  PubMed  Google Scholar 

  38. Ekdahl KN, Soveri I, Hilborn J, Fellström B, Nilsson B (2017) Cardiovascular disease in haemodialysis: role of the intravascular innate immune system. Nat Rev Nephrol 13:285–296. https://doi.org/10.1038/nrneph.2017.17

    Article  CAS  PubMed  Google Scholar 

  39. Ostermann M, Lumlertgul N (2021) Acute kidney injury in ECMO patients. Crit Care 25(1):313. https://doi.org/10.1186/s13054-021-03676-5

    Article  PubMed  PubMed Central  Google Scholar 

  40. Williams J, Gilchrist M, Strain D, Fraser D, Shore A (2020) The systemic microcirculation in dialysis populations. Microcirculation 27:e12613. https://doi.org/10.1111/micc.12613

    Article  PubMed  Google Scholar 

  41. Ahmadmehrabi S, Tang WHW (2018) Hemodialysis-induced cardiovascular disease. Semin Dial 31:258–267. https://doi.org/10.1111/sdi.12694

    Article  PubMed  PubMed Central  Google Scholar 

  42. Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K (2016) Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol 27:3758–3768. https://doi.org/10.1681/ASN.2015101142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lee MJ, Park JT, Park KS, Kwon YE, Oh HJ, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW, Han SH (2017) Prognostic value of residual urine volume, GFR by 24-hour urine collection, and egfr in patients receiving dialysis. Clin J Am Soc Nephrol 12:426–434. https://doi.org/10.2215/CJN.05520516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Krediet RT (2017) Preservation of residual kidney function and urine volume in patients on dialysis. Clin J Am Soc Nephrol 12:377–379. https://doi.org/10.2215/CJN.00330117

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mair RD, Sirich TL, Meyer TW (2018) Uremic toxin clearance and cardiovascular toxicities. Toxins (Basel) 10:226. https://doi.org/10.3390/toxins10060226

    Article  CAS  Google Scholar 

  46. Kandouz S, Mohamed AS, Zheng Y, Sandeman S, Davenport A (2016) Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration. Hemodial Int 20:610–617. https://doi.org/10.1111/hdi.12414

    Article  PubMed  Google Scholar 

  47. Sirich TL, Fong K, Larive B, Beck GJ, Chertow GM, Levin NW, Kliger AS, Plummer NS, Meyer TW, Frequent Hemodialysis Network (FHN) Trial Group (2017) Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. Kidney Int 91:1186–1192. https://doi.org/10.1016/j.kint.2016.11.002

    Article  CAS  PubMed  Google Scholar 

  48. Toth-Manikowski SM, Sirich TL, Meyer TW, Hostetter TH, Hwang S, Plummer NS, Hai X, Coresh J, Powe NR, Shafi T (2020) Contribution of “clinically negligible” residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant 35:846–853. https://doi.org/10.1093/ndt/gfz042

    Article  CAS  PubMed  Google Scholar 

  49. Murea M, Deira J, Kalantar-Zadeh K, Casino FG, Basile C (2021) The spectrum of kidney dysfunction requiring chronic dialysis therapy: Implications for clinical practice and future clinical trial. Semin Dial. https://doi.org/10.1111/sdi.13027

    Article  PubMed  Google Scholar 

  50. United States Renal Data System Annual Data Report 2020 (2021) Chronic kidney disease (CKD) in the United States: chapter 8: transition of care in chronic kidney disease. https://adr.usrds.org/2020/chronic-kidney-disease/8-transition-of-care-in-chronic-kidneydisease. Accessed 30 Nov 2021

  51. Murea M, Flythe JE, Anjay R, Emaad AM, Gupta N, Kovach C, Vachharajani TJ, Kalantar-Zadeh K, Casino FG, Basile C (2022) Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one. Curr Opin Nephrol Hypertens 31:92–99. https://doi.org/10.1097/MNH.0000000000000754

    Article  PubMed  Google Scholar 

  52. Judge C, Murphy RP, Cormican S, Smyth A, O’Halloran M, O’Donnell M (2020) Adaptive design methods in dialysis clinical trials: a systematic review protocol. BMJ Open 10:e036755. https://doi.org/10.1136/bmjopen-2019-036755

    Article  PubMed  PubMed Central  Google Scholar 

  53. Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, Holmes J, Mander AP, Odondi L, Sydes MR, Villar SS, Wason JMS, Weir CJ, Wheeler GM, Yap C, Jaki T (2018) Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Med 16:29. https://doi.org/10.1186/s12916-018-1017-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Murea M (2021) Precision medicine approach to dialysis including incremental and decremental dialysis regimens. Curr Opin Nephrol Hypertens 30:85–92. https://doi.org/10.1097/MNH.0000000000000667

    Article  PubMed  Google Scholar 

  55. Monti S, Tamayo P, Mesirov J, Golub T (2003) Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52:91–118. https://doi.org/10.1023/A:1023949509487

    Article  Google Scholar 

  56. Perl J, Bargman JM (2009) The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis 53:1068–1081. https://doi.org/10.1053/j.ajkd.2009.02.012

    Article  PubMed  Google Scholar 

  57. Vilar E, Farrington K (2011) Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24:487–494. https://doi.org/10.1111/j.1525-139X.2011.00968.x

    Article  PubMed  Google Scholar 

  58. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56:348–358. https://doi.org/10.1053/j.ajkd.2010.03.020

    Article  PubMed  PubMed Central  Google Scholar 

  59. Tótoli C, Carvalho AB, Ammirati AL, Draibe SA, Canziani MEF (2019) Associated factors related to chronic kidney disease progression in elderly patients. PLoS ONE 14:e0219956. https://doi.org/10.1371/journal.pone.0219956

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Murea M, Moossavi S, Garneata L, Kalantar-Zadeh K (2019) Narrative review of incremental hemodialysis. Kidney Int Rep 5:135–148. https://doi.org/10.1016/j.ekir.2019.11.014

    Article  PubMed  PubMed Central  Google Scholar 

  61. Deira J, Suárez MA, López F, García-Cabrera E, Gascón A, Torregrosa E, García GE, Huertas J, de la Flor JC, Puello S, Gómez-Raja J, Grande J, Lerma JL, Corradino C, Musso C, Ramos M, Martín J, Basile C, Casino FG (2019) IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients. BMC Nephrol 20:8. https://doi.org/10.1186/s12882-018-1189-6

    Article  PubMed  PubMed Central  Google Scholar 

  62. Fernández Lucas M, Ruíz-Roso G, Merino JL, Sánchez R, Bouarich H, Herrero JA, Muriel A, Zamora J, Collado A (2020) Initiating renal replacement therapy through incremental haemodialysis: protocol for a randomized multicentre clinical trial. Trials 21:206. https://doi.org/10.1186/s13063-020-4058-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Casino FG, Basile C, Kirmizis D, Kanbay M, van der Sande F, Schneditz D, Mitra S, Davenport A, Gesuldo L, Eudial Working Group of ERA-EDTA (2020) The reasons for a clinical trial on incremental haemodialysis. Nephrol Dial Transplant 35:2015–2019. https://doi.org/10.1093/ndt/gfaa220

    Article  CAS  PubMed  Google Scholar 

  64. Murea M, Moossavi S, Fletcher AJ, Jones DN, Sheikh HI, Russell G, Kalantar-Zadeh K (2021) Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial. BMJ Open 11:e047596. https://doi.org/10.1136/bmjopen-2020-047596

    Article  PubMed  PubMed Central  Google Scholar 

  65. Engelbrecht BL, Kristian MJ, Inge E, Elizabeth K, Guldager LT, Helbo TL, Jeanette F (2021) Does conservative kidney management offer a quantity or quality of life benefit compared to dialysis? A systematic review. BMC Nephrol 22:307. https://doi.org/10.1186/s12882-021-02516-6

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding agency granted the present study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Basile.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

Statement of human rights, statement on the welfare of animals: this article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

No verbal and written informed consent was necessary for this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deira, J., Murea, M., Kalantar-Zadeh, K. et al. Does delivering more dialysis improve clinical outcomes? What randomized controlled trials have shown. J Nephrol 35, 1315–1327 (2022). https://doi.org/10.1007/s40620-022-01246-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-022-01246-8

Keywords

Navigation